ID

12806

Description

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Elderly Patients With First Line Acute Lymphoblastic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT01523782

Link

https://clinicaltrials.gov/show/NCT01523782

Keywords

  1. 12/21/15 12/21/15 -
Uploaded on

December 21, 2015

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Acute Lymphoblastic Leukemia NCT01523782

Eligibility Acute Lymphoblastic Leukemia NCT01523782

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
aged ≥ 55 years
Description

age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
newly diagnosed all without prior treatment
Description

all

Data type

boolean

Alias
UMLS CUI [1]
C0023449
patient capable to receive polychemotherapy (who < 2)
Description

polychemotherapy

Data type

boolean

Alias
UMLS CUI [1]
C0013218
with or without meningeal disease
Description

meningeal leukemia

Data type

boolean

Alias
UMLS CUI [1]
C0948840
signed informed consent forms
Description

informed consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
subscribed to social security insurance
Description

social security insurance

Data type

boolean

Alias
UMLS CUI [1]
C0021682
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
all t(9;22) and/or bcr-abl positive
Description

all t(9;22) and/or bcr-abl positive

Data type

boolean

Alias
UMLS CUI [1]
C0279592
UMLS CUI [2]
C2861580
general state incompatible with chemotherapy treatment (who>2)
Description

general state incompatible with chemotherapy treatment

Data type

boolean

Alias
UMLS CUI [1]
C1298650
UMLS CUI [2]
C0392920
presenting with a general or visceral contraindication to intensive treatment
Description

contraindication

Data type

boolean

Alias
UMLS CUI [1]
C1301624
patient with another cancer other than all
Description

malignancy

Data type

boolean

Alias
UMLS CUI [1]
C0006826
severe evolutive infection or hiv seropositive or active hepatitis related to b or c viral infection
Description

communicable disease

Data type

boolean

Alias
UMLS CUI [1]
C0009450
prior treatment with l-asparaginase (irrespective of the form)
Description

l-asparaginase

Data type

boolean

Alias
UMLS CUI [1]
C0003993
history of grade 3 transfusional incident (life threatening)
Description

transfusional incident

Data type

boolean

Alias
UMLS CUI [1]
C0161840
presenting rare and/or dangerous anti-erythrocyte antibodies thus leading to the unavailable of a phenotype compatible red blood cells
Description

anti-erythrocyte antibodies

Data type

boolean

Alias
UMLS CUI [1]
C1112584
included in another clinical trial during the last 4weeks.
Description

study subject participation status

Data type

boolean

Alias
UMLS CUI [1]
C2348568

Similar models

Eligibility Acute Lymphoblastic Leukemia NCT01523782

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
age
Item
aged ≥ 55 years
boolean
C0001779 (UMLS CUI [1])
all
Item
newly diagnosed all without prior treatment
boolean
C0023449 (UMLS CUI [1])
polychemotherapy
Item
patient capable to receive polychemotherapy (who < 2)
boolean
C0013218 (UMLS CUI [1])
meningeal leukemia
Item
with or without meningeal disease
boolean
C0948840 (UMLS CUI [1])
informed consent
Item
signed informed consent forms
boolean
C0021430 (UMLS CUI [1])
social security insurance
Item
subscribed to social security insurance
boolean
C0021682 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
all t(9;22) and/or bcr-abl positive
Item
all t(9;22) and/or bcr-abl positive
boolean
C0279592 (UMLS CUI [1])
C2861580 (UMLS CUI [2])
general state incompatible with chemotherapy treatment
Item
general state incompatible with chemotherapy treatment (who>2)
boolean
C1298650 (UMLS CUI [1])
C0392920 (UMLS CUI [2])
contraindication
Item
presenting with a general or visceral contraindication to intensive treatment
boolean
C1301624 (UMLS CUI [1])
malignancy
Item
patient with another cancer other than all
boolean
C0006826 (UMLS CUI [1])
communicable disease
Item
severe evolutive infection or hiv seropositive or active hepatitis related to b or c viral infection
boolean
C0009450 (UMLS CUI [1])
l-asparaginase
Item
prior treatment with l-asparaginase (irrespective of the form)
boolean
C0003993 (UMLS CUI [1])
transfusional incident
Item
history of grade 3 transfusional incident (life threatening)
boolean
C0161840 (UMLS CUI [1])
anti-erythrocyte antibodies
Item
presenting rare and/or dangerous anti-erythrocyte antibodies thus leading to the unavailable of a phenotype compatible red blood cells
boolean
C1112584 (UMLS CUI [1])
study subject participation status
Item
included in another clinical trial during the last 4weeks.
boolean
C2348568 (UMLS CUI [1])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial